Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Pasterk Lisa |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Curcic, S; Holzer, M; Pasterk, L; Knuplez, E; Eichmann, TO; Frank, S; Zimmermann, R; Schicho, R; Heinemann, A; Marsche, G
Lysophospholipid-enriched HDL suppresses platelet activation
23rd Scientific Symposium of the Austrian Pharmacological Society (APHAR) ; SEP 28-29, 2017; Innsbruck, AUSTRIA. 2017.
[Poster]
Curcic, S; Holzer, M; Pasterk, L; Knuplez, E; Eichmann, TO; Frank, S; Zimmermann, R; Schicho, R; Heinemann, A; Marsche, G.
Secretory phospholipase A2 modified HDL potently inhibits platelet activation
9th ÖGMBT Annual Meeting; SEP 25-27, 2017; Innsbruck, AUSTRIA. 2017.
[Poster]
Curcic, S; Holzer, M; Pasterk, L; Heinemann, A; Marsche, G
Secretory phospholipase A2 modified HDL suppresses platelet activation and platelet-leukocyte crosstalk
22nd Scientific Symposium of the Austrian Pharmacological Society (APHAR); SEP 8-10, 2016; Vienna, AUSTRIA. 2016.
[Poster]
Marsche, G; Heinemann, A; Pasterk, L
PLASMA ADVANCED OXIDIZED PROTEIN PRODUCTS PROMOTE PLATELET-ENDOTHELIAL CROSSTALK AND ENDOTHELIAL TISSUE FACTOR EXPRESSION
ATHEROSCLEROSIS. 2016; 252: E23-E24.-Congress of the European-Atherosclerosis-Society (EAS); MAY 29-JUN 01, 2016; Innsbruck, AUSTRIA.
Doi: 10.1016/j.atherosclerosis.2016.07.308
[Oral Communication]
Web of Science
FullText
FullText_MUG
Pasterk, L; Lemesch, S; Leber, B; Trieb, M; Curcic, S; Stadlbauer, V; Schuligo, R; Schicho, R; Heinemann, A; Marsche, G
Plasma Advanced-Oxidized Protein Products Promote Platelet-Endothelial Crosstalk and Endothelial Tissue Factor Expression
Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) Scientific Sessions; MAY 5-7,2016; Nashville, USA. 2016.
[Poster]
Pasterk, L; Lemesch, S; Leber, B; Trieb, M; Curcic, S; Stadlbauer, V; Schuligo, R; Schicho, R; Heinemann, A; Marsche, G;
The role of Plasma advanced-oxidized protein products on platelets and platelet-endothelial interactions
22nd Scientific Symposium of the Austrian Pharmacological Society (APHAR); SEP 8-10, 2016; Vienna, Austria. 2016.
[Poster]
Pasterk,L; Lemesch,S; Stadlbauer,V; Heinemann, A; Marsche, G
Oxidized plasma albumin promotes platelet-endothelial crosstalk and tissue factor expression
EAS 2016; MAY 29 - JUN 1; Insbruck, AUSTRIA. 2016.
[Poster]
Trieb, M; Horvath, A; Birner-Gruenberger, R; Stadlbauer, V; Pasterk, L; Heinemann, A; Marsche, G
HDL Functionality And Liver Disease Mortality – A Causal Role For HDL In Cirrhosis?
22nd Scientific Symposium of the Austrian Pharmacological Society (APHAR); SEP 8-10, 2016; Vienna, AUSTRIA. 2016.
[Poster]
Trieb, M; Horvath, A; Stadlbauer, V; Taschler, U; Curcic, S; Holzer, M; Pasterk, L; Heinemann, A; Marsche, G
Liver Disease Alters HDL Composition, Metabolism and Function
Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) Scientific Sessions; MAY 5-7, 2016; Nashville, USA. 2016.
[Poster]
Appierto, M; Trieb, M; Pasterk, L; curcis, S; Holzer, M; Frank, S; Marsche, G
Maturation of HDL is impaired in cardiovascular disease
International Student Congress 2015; JUN 4-6, 2015; Graz, AUSTRIA. 2015.
[Oral Communication]
Appierto,M;Trieb, M;Pasterk, L; Curcic, S; Holzer, M; Frank, S; Marsche, G;
Maturation of HDL is impaired in cardiovascular disease
AAS meeting 2015; MAY 8-9 , 2015; St. Gilgen. 2015.
[Oral Communication]
Curcic, S; Holzer, M; Frei, R; Pasterk, L; Heinemann, A; Marsche, G
Neutrophil effector responses are fully suppressed by secretory phospholipase A2-modified HDL
21st Scientific Symposium of the Austrian Pharmacological Society (APHAR)
; SEP 16-18, 2015; Graz, AUSTRIA. 2015.
[Poster]
Curcic, S; Holzer, M; Frei, R; Pasterk, L; Heinemann, A; Marsche, G
Secretory phospholipase A2 shows potent anti-inflammatory effects on neutrophils
22nd Annual Meeting of the Austrian Atherosclerosis Society (AAS); MAY 8-9, 2015; St. Gilgen/Wolfgangsee, AUSTRIA. 2015.
[Oral Communication]
Pasterk, L; Lemesch, S; Leber, B; Trieb, M; Curcic, S; Stadlbauer, V; Schuligoi, R; Schicho,R; Heinemann, A; Marsche,G
Plasma advanced-oxidized protein products promote platelet-endothelial crosstalk and endothelial tissue factor expression
Mini-Symposium "The immune system in kidney and liver disease"; APR 21, 2015; Graz, AUSTRIA. 2015.
[Oral Communication]
Pasterk, L; Lemesch, S; Leber, B; Trieb, M; Curcic, S; Stadlbauer, V; Schuligoi, R; Schicho,R; Heinemann, A; Marsche,G,
Plasma advanced-oxidized protein products promote platelet-endothelial crosstalk and endothelial tissue factor expression
INFLAME - Symposium on Inflammation & Immunology; SEP 13-15, 2015; Graz, AUSTRIA. 2015.
[Oral Communication]
Pasterk, L; Lemesch, S; Trieb, M; Curcic, S; Appierto, M; Stadlbauer, V; Schuligoi, R; Heinemann, A; Marsche, G
Advanced-oxidized protein products activate platelets through CD36, promoting platelet-endothelial crosstalk and tissue factor expression
AAS meeting ; MAI 8-9, 2015; St. Gilgen, AUSTRIA. 2015.
[Poster]
Trieb, M; Horvath, A; Spindelböck, W; Stadlbauer, V; Stauber, R; Holzer, M; Pasterk, L; Taschler, U; Heinemann, A; Marsche, G
Cirrhosis alters HDL metabolism and function
INFLAME - Symposium on Inflammation & Immunology; SEP 13-15, 2015; Graz. 2015.
[Poster]
Trieb, M; Horvath, A; Spindelböck, W; Stadlbauer, V; Stauber, RE; Holzer, M; Pasterk, L; Heinemann, A; Marsche, G
Metrics of HDL functions are markedly impaired in cirrhosis
22nd Annual Meeting of the Austrian Atherosclerosis Society (AAS); MAY 8-9, 2015; St. Gilgen/Wolfgangsee, AUSTRIA. 2015.
[Oral Communication]
Trieb, M; Horvath, A; Spindelböck, W; Stadlbauer, V; Stauber, RE; Pasterk, L; Holzer, M; Marsche, G
Liver cirrhosis, high–density lipoproteins and anti-inflammatory and endothelial regenerative activities of serum
Mini-Symposium "The immune system in kidney and liver disease"; APR 21, 2015; Graz, AUSTRIA. 2015.
[Oral Communication]
Appierto, M; Trieb, M; Pasterk, L; Ćurčić, S; Holzer, M;Frank, S; Marsche, G
Maturation of HDL is impaired in cardiovascular disease.
Doctoral Day 2014; DEC 10, 2014; Graz, AUSTRIA. 2014.
[Oral Communication]
Appierto, M; Trieb, M; Pasterk, L; Ćurčić, S; Holzer, M;Frank, S; Marsche, G.
HDL, inflammation and cardiovascular disease
DK-MOLIN Retreat ; OKT 29-30 , 2014; Seggau, AUSTRIA. 2014.
[Oral Communication]
Curcic, S; Holzer, M; Frei, R; Pasterk, L; Heinemann, A; Marsche, G
Secretory phospholipase A2 modified HDL fully suppresses neutrophil effector responses: Central role of palmitoyl-lysophosphatydilcholine.
Doctoral Day 2014; DEZ 10, 2014; Graz, AUSTRIA. 2014.
[Poster]
Lemesch , S; Leber, B; Ribitsch, W; Schilcher, G; Horvath, A; Hafner-Gießauf, H; Spindelboeck, W; Pasterk, L; Marsche, G; Zettel, G; Tawdrous, M; Rosenkranz, A; Stadlbauer, V
Eine Nierentransplantation kann sich positiv auf die Funktion neutrophiler Granulozyten und den oxidativen Stress auswirken.
Transplant International, John Wiley & Sons, Ltd. 2014; 27(s4):1-27.-Austrotransplant; 15-17 Okt, 2014; Bad Ischl, Austria.
[Oral Communication]
FullText
Lemesch, S; Leber, B; Ribitsch, W; Schilcher, G; Horvath, A; Hafner-Giessauf, H; Spindelboeck, W; Pasterk, L; Marsche, G; Zettel, G; Tawdrous, M; Rosenkranz, A; Stadlbauer, V
KIDNEY TRANSPLANT MAY BE POSITIVE ON THE FUNCTION NEUTROPHILER GRANULOCYTES AND THE OXIDATIVE STRESS EFFECT
TRANSPL INT. 2014; 27: 6-6.-Austrotranspalnt; 15-17 Okt, 2014; Bad Ischl, Austria.
[Oral Communication]
Web of Science
Lemesch, S; Leber, B; Ribitsch, W; Schilcher, G; Horvath, A; Pasterk, L; Marsche, G; Spindelboeck, W; Hafner-Giessauf, H; Zettel, G; Tawdrous, M; A.R. Rosenkranz,AR; Stadlbauer, V
THE LEAKY GUT IN PATIENTS WITH RENAL DISEASE
Abstract. 2014; -ERA-EDTA Congress; SEP 6-9, 2014; Berlin, GERMANY.
[Poster]
Lemesch, S; Leber, B; Ribitsch, W; Schilcher, G; Horvath, A; Pasterk, L; Marsche, G; Spindelboeck, W; Hafner-Giessauf, H; Zettel, G; Tawdrous, M; Rosenkranz, A; Stadlbauer, V
Positiver Effekt der Nierentransplantation auf die Funktion neutrophiler Granulozyten und oxidativen Stress.
Austian Journal of Hypertension. 2014; 18(3):110-128.-Jahrestagung Nephrologie &
Hypertensiologie; 18-22 Sep, 2014; Baden, AUstria.
[Poster]
FullText
Lemesch, S; Leber, B; Ribitsch, W; Schilcher, G; Horvath, A; Pasterk, L; Marsche, G; Spindelboeck, W; Hafner-Giessauf, H; Zettel, G; Tawdrous, M; Rosenkranz, A; Stadlbauer, V
The leaky gut in patients with chronic kidney disease
UEG Journal. 2014; 2(suppl1):A132-A605.-UEGW; 18-22 Okt, 2014; Vienna, Austria.
[Poster]
FullText
Lemesch, S; Leber, B; Ribitsch, W; Schilcher, G; Horvath, A; Pasterk, L; Marsche, G; Spindelboeck, W; Hafner-Giessauf, H; Zettel, G; Tawdrous, M; Rosenkranz, A; Stadlbauer, V
The leaky gut in patients with renal disease
Abstract-USB Stick. 2014; -DGfN; 6-9 Sep, 2014; Berlin, Germany.
[Poster]
Lemesch ,S; Ribitsch, W; Leber, B; Schilcher, G; Horvath, A; Pasterk, L; Marsche, G; Spindelboeck, W; Hafner-Giessauf, H; Zettel, G; Tawdrous, M; A.R. Rosenkranz, AR; Stadlbauer, V;
POSTIVER EFFEKT DER NIERENTRANSPLANTATION AUF DIE FUNKTION NEUTROPHILER GRANULOZYTEN.
Jahrestagung Nephrologie und Hypertensiologie; 18.-20. Sept; Baden, AUSTRIA. 2014.
[Poster]
Pasterk, L; Trieb, M; Curcic, S; Appierto, M; Schuligoi, R; Heinemann, A; Marsche, G
Uremia-induced oxidative modifications convert plasma albumin into platelet activators
APHAR ; SEP 26-27; Innsbruck, AUSTRIA. 2014.
[Poster]
Pasterk, L; Trieb, M; Curcic, S; Appierto, M; Schuligoi, R; Heinemann, A; Marsche, G
Uremia-induced oxidative modifications convert plasma albumin into platelet activators.
Retreat DK-MOLIN; OCT 29-30; Seggau, Austria. 2014.
[Poster]
Pasterk, L; Trieb, M; Curcic, S; Appierto, M; Schuligoi, R; Heinemann, A; Marsche, G
Uremia-induced oxidative modifications convert plasma albumin into platelet activators
Docteral Day ; DEC 10, 2014; Graz, AUSTRIA. 2014.
[Poster]
Sanja Curcic, Michael Holzer, Robert Frei, Lisa Pasterk, Akos Heinemann and Gunther Marsche
Secretory phospholipase A2 modified HDL shows potent anti-inflammatory effects on neutrophils
ZMF (Center for Medical Research) 10th Anniversary; JUL 17-18, 2014; Graz, AUSTRIA. 2014.
[Poster]
Sanja Curcic, Michael Holzer, Robert Frei, Lisa Pasterk, Akos Heinemann and Gunther Marsche
Secretory phospholipase A2 modified HDL fully suppresses neutrophil effector responses: Central role of palmitoyl-lysophosphatydilcholine
20th Scientific Symposium of the Austrian Pharmacological Society (APHAR); SEP 26-27; Innsbruck, Austria. 2014.
[Poster]
Sanja Curcic, Michael Holzer, Robert Frei, Lisa Pasterk, Akos Heinemann and Gunther Marsche
Secretory phospholipase A2 modified HDL fully suppresses neutrophil effector responses: Central role of palmitoyl-lysophosphatydilcholine
4th European Lipidomic Meeting; SEP 22-24; Graz, AUSTRIA. 2014.
[Poster]
Trieb, M; Horvath, A; Spindelböck, W; Stadlbauer, V; Stauber, RE; Pasterk, L; Marsche, G
Low HDL levels in cirrhotic patients are linked to severely impaired anti-inflammatory and endothelial regenerative activities of serum
2nd Retreat, Doctoral College-Molecular Fundamentals of Inflammation; OKT 29-30, 2014; Seggau, AUSTRIA. 2014.
[Poster]
Trieb, M; Horvath, A; Spindelböck, W; Stadlbauer, V; Stauber, RE; Pasterk, L; Marsche, G
Low HDL levels in cirrhotic patients are linked to severely impaired anti-inflammatory and endothelial regenerative activities of serum
Doctoral Day; DEC 10, 2014; Graz, AUSTRIA. 2014.
[Poster]
Trieb, M; Horvath, A; Stadlbauer, V; Pasterk, L; Marsche, G
Liver cirrhosis is associated with reduced anti-inflammatory capacity of serum: Central role of high-density lipoprotein
20th Scientific Symposium of the Austrian Pharmacological Society; SEP 26-27, 2014; Innsbruck, AUSTRIA. 2014.
[Poster]
Trieb, M; Horvath A; Stadlbauer V; Pasterk L; Marsche G
Liver cirrhosis is associated with reduced anti-inflammatory capacity of serum: Central role of high-density lipoprotein
Gordon Research Seminar; JUNE 14-15, 2014; Waterville Valley, USA. 2014.
[Poster]
Trieb M; Horvath A; Stadlbauer V; Pasterk L; Marsche G
Liver cirrhosis is associated with reduced anti-inflammatory capacity of serum: Central role of high-density lipoprotein
Gordon Research Conference; JUNE 15-20, 2014; Waterville Valley, USA. 2014.
[Poster]
Holzer, M; Wolf, P; Inzinger, M; Trieb, M; Curcic, S; Pasterk, L; Weger, W; Heinemann, A; Marsche, G.
Anti-psoriatic therapy recovers high-density lipoprotein composition and function
Intrinsic Activity. 2013; 1(1):-Joint Meeting of the Austrian Neuroscience Association (13th ANA Meeting) and the Austrian Pharmacological Society (19th Scientific Symposium of APHAR) ; SEP 16-19, 2013; Vienna, AUSTRIA.
[Poster]
FullText
Pasterk, L; Trieb, M; Schilcher, G; Rosenkranz, AR; Heinemann, A; Marsche, G
The Effect of Oxidized Plasma Albumin on Platelet Function
Doctoral Day 2013; DEC 9, 2013; Graz, AUSTRIA. 2013.
[Oral Communication]
Pasterk, L; Trieb, M; Schilcher, G; Rosenkranz, AR; Heinemann, A; Marsche, G
The Effect of Oxidized Plasma Albumin on Platelet Function
first retreat, DK-MOLIN; NOV 6-7, 2013; Seggau, AUSTRIA. 2013.
[Oral Communication]
Trieb, M; Horvath, A; Stadlbauer-Köllner, V; Pasterk, L; Holzer, M; Marsche, G
The anti-inflammatory capacity of serum is severely impaired in patients with liver disease and causally linked to a defective HDL metabolism.
Doctoral Day; DEZ 9, 2013; Graz, AUSTRIA. 2013.
[Poster]
Trieb, M; Horvath, A; Stadlbauer-Köllner, V; Pasterk, L; Holzer, M; Marsche, G
The anti-inflammatory capacity of serum is severely impaired in patients with liver disease and causally linked to a defective HDL metabolism.
1st Retreat, Doctoral College-Molecular Fundamentals of Inflammation; NOV 6-7, 2013; Seggau, AUSTRIA. 2013.
[Oral Communication]
Philipose, S; Konya, V; Lazarevic, M; Pasterk, L; Marsche, G; Frank, S; Peskar, BA; Heinemann, A; Schuligoi, R;
Laropiprant Attenuates EP3 and TP Prostanoid Receptor-Mediated Thrombus Formation.
BMC Pharmacology and Toxicology 2012
18th Scientific Symposium of the Austrian
Pharmacological Society (APHAR). 2012; -Austrian Pharmacological Society (APHAR) Joint Meeting with the Croatian, Serbian and Slovenian Pharmacological Societies; SEP 20-21,2012; Graz, Austria.
[Poster]
FullText